These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26601784)

  • 1. The multifaceted functions of C/EBPα in normal and malignant haematopoiesis.
    Ohlsson E; Schuster MB; Hasemann M; Porse BT
    Leukemia; 2016 Apr; 30(4):767-75. PubMed ID: 26601784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-inhibiting activity of transcription factor C/EBPalpha, its role in haematopoiesis and its tumour suppressor or oncogenic properties in leukaemias.
    Fuchs O
    Folia Biol (Praha); 2007; 53(3):97-108. PubMed ID: 17580000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of CCAAT/enhancer-binding protein alpha or PU.1 in hematopoietic stem cells leads to their reduced self-renewal and proliferation.
    Fukuchi Y; Ito M; Shibata F; Kitamura T; Nakajima H
    Stem Cells; 2008 Dec; 26(12):3172-81. PubMed ID: 18787208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C/EBPα is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors.
    Hasemann MS; Lauridsen FK; Waage J; Jakobsen JS; Frank AK; Schuster MB; Rapin N; Bagger FO; Hoppe PS; Schroeder T; Porse BT
    PLoS Genet; 2014 Jan; 10(1):e1004079. PubMed ID: 24415956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C/EBPα in normal and malignant myelopoiesis.
    Friedman AD
    Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the C/EBPα signaling pathway in acute myeloid leukemia (Review).
    Song G; Wang L; Bi K; Jiang G
    Oncol Rep; 2015 May; 33(5):2099-106. PubMed ID: 25760953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell.
    Schuster MB; Porse BT
    Biofactors; 2009; 35(3):227-31. PubMed ID: 19322763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells.
    Shimokawa T; Nunomura S; Fujisawa D; Ra C
    Biochim Biophys Acta; 2013 Nov; 1829(11):1207-17. PubMed ID: 24076158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis.
    Loomis KD; Zhu S; Yoon K; Johnson PF; Smart RC
    Cancer Res; 2007 Jul; 67(14):6768-76. PubMed ID: 17638888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBPalpha: a tumour suppressor in multiple tissues?
    Schuster MB; Porse BT
    Biochim Biophys Acta; 2006 Aug; 1766(1):88-103. PubMed ID: 16616425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation.
    Pedersen TA; Kowenz-Leutz E; Leutz A; Nerlov C
    Genes Dev; 2001 Dec; 15(23):3208-16. PubMed ID: 11731483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBPalpha and the pathophysiology of acute myeloid leukemia.
    Mueller BU; Pabst T
    Curr Opin Hematol; 2006 Jan; 13(1):7-14. PubMed ID: 16319681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
    Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
    Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation.
    Wang D; Sun T; Xia Y; Zhao Z; Sheng X; Li S; Ma Y; Li M; Su X; Zhang F; Li P; Ma D; Ye J; Lu F; Ji C
    Nat Commun; 2023 Oct; 14(1):6907. PubMed ID: 37903757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
    Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
    Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple ways of C/EBPalpha inhibition in myeloid leukaemia.
    Trivedi AK; Pal P; Behre G; Singh SM
    Eur J Cancer; 2008 Jul; 44(11):1516-23. PubMed ID: 18515086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction.
    Yang L; Jiang Y; Wu SF; Zhou MY; Wu YL; Chen GQ
    Carcinogenesis; 2008 Feb; 29(2):291-8. PubMed ID: 18024476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.
    Lourenço AR; Coffer PJ
    Oncogene; 2017 Sep; 36(37):5221-5230. PubMed ID: 28504718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
    Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.